MIStar
Apollo Medical Imaging Technology is a clinically-driven medical imaging software company specializing in the creation of advanced image processing software for clinical and research applications. Their flagship product, MIStar, is a fast, economical, and easy-to-use software package that provides a broad spectrum of advanced functions and cost-effective cross-modality solutions for clinicians and the OEMs that serve them. MIStar supports various imaging modalities, including CT, MR, NM, and PET, and offers advanced modules such as CT Perfusion for stroke, brain tumor, body tumor, liver, kidney, and prostate; DSC-MRI for stroke; DCE-MRI for brain tumor, breast, body tumor, liver, kidney, and prostate; DWI & ADC; DTI Fiber Tractography; NM Renogram Analysis; and Image Fusion. The software features data access and image input through DICOM networking functions, an intuitive clinical database, and easy anonymization and archiving.
Learn more
NeuroICH
NeuroICH is an AI module capable of detecting cerebral hemorrhage. This is a critical step in identifying and treating stroke patients. Quick assessment and imaging interpretation are essential, as "time is brain," and this technology has the potential to save lives and prevent disabilities due to stroke. It is now FDA SaMD Approved.
Learn more
Elements Contrast Clearance Analysis
Brainlab's Elements Contrast Clearance Analysis is an MRI-based methodology designed to differentiate regions of contrast clearance and accumulation in brain tumor datasets. This high-resolution analysis provides additional insights to support ongoing assessment and decision-making in clinical specialties such as radiosurgery, radiation oncology, neurosurgery, neuro-oncology, and neuroradiology. The process involves acquiring two standard 3D T1-weighted MRIs, one approximately 5 minutes and another 60 to 105 minutes after the injection of a standard dose of contrast agent. The first series is subtracted from the second to generate volumetric maps that distinguish regions of contrast clearance (depicted in blue) from contrast accumulation (depicted in red). These results enable clinicians to assess radiation effects versus tumor regrowth, facilitating more informed decisions for initial and follow-up treatments.
Learn more
IntelliSpace
IntelliSpace Portal 9.0, with over 70 clinical applications in total, is an advanced visualization platform that offers a single integrated solution to help you work quickly and efficiently with increased diagnostic confidence – especially during reading and follow-up of multi-faceted cases. With the aging population, neurodegenerative disease is on the rise worldwide. Since neurological disorders are often chronic, patients require long-term follow-up, but changes in the brain can be subtle and hard to detect. IntelliSpace Portal 9.0 offers a host of new and enhanced neuro applications such as NeuroQuant®¹,LoBi and CT Brain Perfusion. These tools are designed to facilitate rapid, objective, quantitative and consistent image evaluation. Given the increasing interest in pulmonary care, IntelliSpace Portal 9.0 offers you one comprehensive toolset to help you track pulmonary disease from detection to follow-up.
Learn more
